Factors associated with subclinical inflammation of wrist joints in rheumatoid arthritis patients with low or no disease activity- a RA ultrasound registry study

被引:1
作者
Wang, Yu-Wei [1 ]
Chen, Jia-Feng [1 ]
Ko, Chi-Hua [1 ]
Cheng, Tien-Tsai [1 ]
Chiu, Wen-Chan [1 ]
Yu, Shan-Fu [1 ]
Hsu, Chung-Yuan [1 ]
Chen, Ying-Chou [1 ]
机构
[1] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Rheumatol, Kaohsiu,123 Ta Pei Rd,Niao Sung Dist, Kaohsiung 833, Taiwan
关键词
Subclinical inflammation; Rheumatoid arthritis; Ultrasound; DAS; 28; Disease activity; REMISSION CRITERIA; CLINICAL REMISSION; SYNOVITIS; STATEMENT; DAMAGE;
D O I
10.1186/s12891-023-06521-8
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
BackgroundTo evaluate the factors to predict subclinical inflammation of wrist joints in patients with RA who are in clinical remission or low disease activity.MethodsGray scale and power Doppler ultrasound were performed on the dorsal radio-lunate of both wrists. The presence of synovitis, comorbidities, and use of disease modifying anti-rheumatic drugs were recorded. A Multivariable forward logistical regression model was used to identify factors associated with subclinical inflammation.ResultsThere were 1248 patients (1010 females, 238 males; mean age: 60.0 +/- 10.5 years ). 57.4% of patients in complete remission and low disease activity had sonographic inflammation. Multivariable forward logistic regression analysis indicated that male sex, smoking are positively associated with inflammation and that age, alcohol consumption, and use of methotrexate, glucocorticoid, or a biological therapy are negatively associated with inflammation. Use of biological agents decreased the risk of inflammation by 40.9%.ConclusionsThere was evidence of subclinical inflammation in most patients who were in low or no disease activity, those with biological therapy had lower risk of subclinical inflammation.
引用
收藏
页数:6
相关论文
共 33 条
  • [31] Tokunaga Takahiro, 2015, Open Rheumatol J, V9, P51, DOI 10.2174/1874312901409010051
  • [32] von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297, 10.1016/S0140-6736(07)61602-X]
  • [33] Delay in imaging versus clinical response: A rationale for prolonged treatment with anti-tumor necrosis factor medication in early rheumatoid arthritis
    Wakefield, Richard J.
    Freeston, Jane E.
    Hensor, Elizabeth M. A.
    Bryer, Domini
    Quinn, Mark A.
    Emery, Paul
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (08): : 1564 - 1567